Immunotherapy in glioblastoma treatment: Current state and future prospects

Glioblastoma remains as the most common and aggressive malignant brain tumor, standing with a poor prognosis and treatment prospective. Despite the aggressive standard care, such as surgical resection and chemoradiation, median survival rates are low. In this regard, immunotherapeutic strategies aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocha Pinheiro, Samuel Luca, Lemos, Fabian Fellipe Bueno, Marques, Hanna Santos, Silva Luz, Marcel, de Oliveira Silva, Luís Guilherme, Faria Souza Mendes dos Santos, Clara, da Costa Evangelista, Karolaine, Calmon, Mariana Santos, Sande Loureiro, Matheus, Freire de Melo, Fabrício
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134201/
https://www.ncbi.nlm.nih.gov/pubmed/37124134
http://dx.doi.org/10.5306/wjco.v14.i4.138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134201/
https://www.ncbi.nlm.nih.gov/pubmed/37124134
http://dx.doi.org/10.5306/wjco.v14.i4.138

Ejemplares similares